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Abstract 
Background: Acute kidney injury (AKI) commonly occurs in hospitalized patients and can lead to serious 
medical complications. But it is preventable and if diagnosed and managed in time it is also potentially 
reversible. Hence several machine learning based predictive models have been built to predict AKI in 
advance from electronic health records (EHR) data. These models to predict inpatient AKI were always 
built to make predictions at a particular time, say 24 or 48 hours from admission; however, hospital stays 
can be several days long and AKI can develop any time within a few hours.   
Materials and Methods: In order to optimally predict AKI before it develops at any time during a hospital 
stay, we present a novel framework in which AKI is continually predicted automatically from EHR data 
over the entire hospital stay instead of at only one particular time. The continual model predicts AKI 
every time a patient’s AKI-relevant variable changes in the EHR. Thus the model is not only independent 
of a particular time for making predictions, but it can also leverage the latest values of all the AKI-
relevant patient variables for making predictions. Using data of 44,691 hospital stays of duration longer 
than 24 hours we evaluated our continual prediction model and compared it with the traditional one-time 
prediction models.  
Results: Excluding hospitals stays in which AKI occurred within 24 hours from admission, the one-time 
prediction model predicting at 24 hours from admission obtained area under ROC curve (AUC) of 0.653 
while the continual prediction model obtained AUC of 0.724. The one-time prediction model that predicts 
at 24 hours obviously cannot predict AKI incidences that occur within 24 hours of admission which when 
included in the evaluation reduced its AUC to 0.57. In comparison, the continual prediction model had 
AUC of 0.709. The continual prediction model also did better than all other one-time prediction models 
predicting at other fixed times.  
Conclusion: By being able to take into account the latest values of AKI-relevant patient variables and by 
not being limited to a particular time of prediction, the continual prediction model out-performed one-
time prediction models in predicting AKI. 
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1. Introduction 
Acute kidney injury (AKI), formerly known as acute renal failure, is a sudden loss of kidney function 
which affects 5-7% of hospitalized patients [1,2,3] and 22-57% of patients in intensive care unit 
[4,5,6,7,8]. AKI can lead to serious medical complications and is potentially fatal. It also results in longer 
hospital stays thus also increasing the associated healthcare cost [1]. Even after resolution, it can 
subsequently lead to severe kidney problems such as chronic kidney disease and progression to dialysis 
dependency. Incidence of AKI is highest in elderly patients [9,10] and its rate has been steadily increasing 
in this population due to increasing number of comorbidities, aggressive medical treatments and greater 
use of nephrotoxic drugs. AKI has a heterogeneous etiology and it often develops stealthily in 
hospitalized patients being treated for other problems; these two factors complicate its diagnosis. 
However, up to 30% of hospital-acquired AKI is preventable [11] if predicted in time. AKI is also 
potentially reversible if diagnosed and managed in time.  
 
Its seriousness as a disease and its preventability together make AKI a perfect candidate for predictive 
analytics. Hence several machine learning based predictive models have been built to predict inpatient 
AKI from electronic health records (EHR) data [12,13]. All these models built in past to predict AKI to 
occur during rest of the hospital stay always had a particular time when the predictions were made, for 
example, at 24 hours after admission [14,15], or at 48 hours after admission [16,17], or around the time of 
a medical intervention [18,19,20]. However, there are two fundamental problems with such models that 
have a fixed time for predicting AKI. First, hospital stays of patients can be several days long during 
which their medical condition can significantly change and after which AKI may develop anytime within 
a few hours. In our data, for example, 39.4% of AKI incidences occurred after five days and 15.7% 
occurred after 10 days from admission. It is thus difficult to predict such incidences too far ahead in time. 
Second, if prediction model has a fixed time of prediction, say 24 hours after admission, then it is bound 
to miss all the AKI incidences that occur within 24 hours from admission. In our data, for example, 
12.8% of AKI incidences occurred within 24 hours and 30.9% of AKI incidences occurred within 48 
hours from admission. Thus the later the time of prediction of a model is the more incidences it will 
naturally miss. Hence neither a too early nor a too late prediction time is desirable for predicting AKI, 
instead, AKI should be predicted continually during the entire inpatient stay in order to optimally predict 
it before it develops. Although this possibility was recently mentioned in a workgroup statement from the 
15th Acute Dialysis Quality Initiative (ADQI) consensus conference [12] as a model that would generate a 
prediction score in real time as each new data value is received, to the best of our knowledge no previous 
work ever built a model to continually predict AKI. 
 
In this study, we introduce a novel framework for predicting AKI continually over hospital stays. A 
trained machine learning model is used to predict AKI every time a patient’s status changes in the EHR, 
for example, when a new medication is prescribed, or a new comorbidity is recorded, or a new laboratory 
test result becomes available. We experimentally show that our continual prediction model obtains a 
superior prediction performance compared to the traditional one-time prediction models. In a recent study 
[21], an AKI prediction model was applied over different time zones of hospital stays in order to 
determine how early AKI can be predicted, for example, 24 hours or 48 hours before it occurs. However, 
their framework can only be used for retrospective evaluation and cannot be used in practice to predict 
AKI, say, 24 hours in advance, because one cannot know AKI’s time of occurrence beforehand in order to 
apply their model 24 hours ahead of that time. In contrast, our continual prediction framework does not 
suffer from this problem and can be used in practice for predicting AKI in advance. It also does not 
require constant monitoring and is designed to work automatically using EHR data and trigger an alarm 
when necessary. Although we focused on AKI in this study, our proposed continual prediction framework 
is general and could also be applied to continually predict other diseases and disorders from EHR data. 
 
We point out that our continual prediction framework is different from other well-known time-related 
data modeling frameworks. There are types of models that utilize repeated measures of variables from 
longitudinal data [22], however, they still make predictions at only one time. In contrast, our continual 
prediction model uses only the latest values of the variables but makes predictions continually over time. 
Survival analysis models [23] predict the time when an event will occur (e.g. time of death) but our 
continual prediction model continually predicts whether an event (e.g. AKI) will occur or not as the 
variables change over time. Multilevel models for change [24] model how variables change over time 
(e.g. to model growth), in contrast, our model is applied continually over time to predict a particular 
event.  In past, researchers have done time series analysis of medical data for various applications 
[25,26,27,28,29] using the aforementioned types of models but they did not do continual prediction. 
Researchers have also built sequential models to discover longitudinal patterns in patient data, for 
example, patterns of disease diagnoses in order to predict the diagnosis for the next hospital admission 
[30,31]. In contrast, our model is not a sequential model but is applied continually over an entire hospital 
stay in order to predict a particular disease as early as possible using the latest values of patient variables.  
 
2. Materials and Methods 
 
2.1. Data Collection 
The data was collected from the EHR of Aurora Health Care’s 15 hospitals. All these hospitals are located 
in the southeastern region of Wisconsin state and use the same EHR system. Structured data along with 
their timestamps for entire hospital stays was collected for all adults older than 60 in the years 2013, 2014 
and 2015 (number of patients=84,480). We focused on hospitalized older adults because occurrence of 
AKI is especially common in this age group [9,10]. Our exclusion criteria were patients who had chronic 
kidney disease stages III, IV and V, and those who were on dialysis. In addition, only hospital stays that 
were longer than 24 hours and in which at least two serum creatinine measurements were taken were 
included. After applying the exclusion criteria, there were 36,614 patients remaining with total 44,691 
hospital stays among them as shown in Figure 1. This study was approved by the Institutional Review 
Board of Aurora Health Care.   
 
2.2. AKI Definition 
We used the AKIN criteria [32] as the definition of AKI. According to it, AKI is determined by either a 
1.5 fold increase or an absolute increase of 0.3 mg/dL in serum creatinine (SCr) within 48 hours. In our 
data, AKI developed in 3,786 hospital stays. Please note that hospital stays are classified as AKI or non-
AKI and not patients because a patient can have multiple hospital stays and may acquire AKI during one 
hospital stay and not during another. The time of the SCr measurement that satisfies the AKIN criteria is 
taken as the time of the AKI incidence. Figure 2 shows the number of AKI incidences that occurred by 
different times from admission. 
 
Figure 1. Flowchart depicting number of patients and hospital stays in the data. 
 Figure 2. Number of AKI incidences by different hours from admission. 
 
In the following subsections we first describe the traditional one-time prediction models for AKI and then 
we describe our new continual prediction model. 
 
2.3. Traditional One-Time Prediction Models for AKI 
The task of an AKI prediction model is to predict in advance whether AKI will develop or not during a 
patient’s hospital stay. Machine learning methods have been used in past to build AKI prediction models 
that classify hospital stays as AKI or non-AKI from various predictive variables, also called features. A 
machine learning method is given training examples of hospital stays in the form of their features 
(described later) and the correct class (AKI or non-AKI). From this training data it learns to predict AKI 
on new hospital stays using only their features.  
 
2.3.1. Time of Prediction 
Most of the past work had chosen a particular time for making predictions, say 24 hours from admission 
[14,15], or 48 hours from admission [16,17], or even at the time of admission [33], while some of the past 
work were not clear about it [34,35]. In the rest of the paper, we call a prediction model built to make 
predictions at 24 hours from admission as one-time-at-24-hour prediction model. When such a model is 
trained, it uses values of the features as they were at 24 hours from admission for all its training examples. 
Then when such a model is applied to predict at 24 hours from admission whether AKI will develop 
during rest of the hospital stay, it uses values of the features as they were at 24 hours from admission 
during that hospital stay.  
 
2.3.2. Features 
Demographic information, comorbidities, medications and laboratory values are the common types of 
features that have been used to predict AKI. In this work, for both one-time and continual models, we 
used the same features that we had also used in our previous study [14]. These features had been decided 
with the help of a nephrologist who is a co-author. The only differences in features from our previous 
study is that in this study for each comorbidity and medication we used separate pre-admission and post-
admission features and also used prior AKI as a feature. Table 1 shows the distribution of the feature 
values in our data across AKI and non-AKI hospital stays for the features that do not change over hospital 
stays. These features include all the demographic features and prior AKI. 
 
Table 1. Distribution of feature values across AKI and non-AKI hospital stays in the data for the features 
that do not change over hospital stays. The p-values for statistical significance were computed using “N-
1” chi-squared test [36] for proportions and using t-test for means.   
Variable AKI (3786) Non-AKI (40905) P-value 
Age 72.99 ± 9.07 73.02 ± 9.25 0.85 
BMI 29.42 ± 8.31 28.50 ± 7.32 < 0.01 
Gender = Male 
Gender = Female 
2031 (53.7%) 
1755 (46.3%) 
20563 (50.3%) 
20342 (49.7%) 
< 0.01 
< 0.01 
Race = White 
Race = Black 
Race = Other 
3340 (88.2%) 
331 (8.8%) 
115 (3.0%) 
37430 (91.5%) 
2440 (6.0%) 
1035 (2.5%) 
< 0.01 
< 0.01 
0.06 
Alcohol Use 1014 (26.8%) 13949 (34.1%) < 0.01 
Tobacco Use 408 (10.8%) 4771 (11.7%) 0.09 
Drug Use 69 (1.8%) 472 (1.2%) < 0.01 
Prior AKI 618 (16.3%) 2838 (6.9%) < 0.01 
 
 
Table 2 shows how the values of laboratory value, comorbidity and medication features are distributed 
across AKI and non-AKI hospital stays in our data. These features can change over hospital stays. 
Comorbidities and medications were binary features (true or false). Laboratory value features were the 
latest numeric values of the test results obtained since five days before admission till during the stay. To 
show that these features change over the course of hospital stays, we have shown the same statistics up to 
24 hours following admission and after 24 hours following admission till AKI incidence or till the end for 
non-AKI hospital stays. For numeric features averages are shown. For this table, hospital stays in which 
AKI developed within 24 hours from admission (483) were excluded because they are not useful for 
comparing feature values up to 24 hours and after 24 hours following admission. Only post-admission 
comorbidity and medication features are shown because they can change over hospital stays. Please note 
that we did not use SCr as a feature because it is used as a gold-standard to determine AKI. In other 
words, the predictive model needs to predict AKI in absence of SCr measurement before the caregivers 
suspect the onset of AKI and order the SCr test. From the table it can be observed that for most features 
the differences between their values for AKI and non-AKI cases become more pronounced later during 
the hospital stays. For example, the difference in the use of diuretics between AKI and non-AKI cases 
was 13.74% up to 24 hours following admission while it was 30.12% after 24 hours following admission. 
This shows that the status of patients change significantly over hospital stays and a one-time prediction 
model (e.g. at 24 hours) will not be able to take this into account for predicting AKI.   
 
2.3.3. Evaluation 
The standard way to evaluate a machine learning model is through ten-fold cross-validation [37]. In this 
process the data is first randomly divided into ten equal parts. Then in each fold, nine parts are used for 
training the model and the remaining part (different in each fold) is used for testing it. The results of all 
the folds are combined and reported. Sensitivity (proportion of positive examples correctly identified) and 
specificity (proportion of negative examples correctly identified) are the most common evaluation 
measures for predictive models. Many machine learning methods give probability (or confidence) of their 
prediction and by varying the threshold value (we used step size of 0.01) on a model’s prediction 
confidence, one can trade-off sensitivity with specificity and thus generate an entire curve between them. 
Traditionally, the curve is plotted between sensitivity (true positive rate) and 1-specificity (false positive 
rate) and is called an ROC curve. The area under this curve (AUC) is one number that conveniently 
summarizes the entire curve. In our results, we report AUC and use it for comparing different models.   
 
Table 2. Distribution of feature values across AKI and non-AKI hospital stays up to 24 hours and after 24 
hours following admission for the features that can change over hospital stays. The hospital stays in 
which AKI developed within 24 hours of admission (483) were excluded for the purpose of this table. The 
differences shown in bold were found to be statistically significant (p < 0.05) using “N-1” chi-squared test 
[36]  for proportions and using t-test for means. 
 Up to 24 hours following admission  After 24 hours following admission 
AKI 
(3,303) 
Non-AKI 
(40,905) 
Difference AKI (3,303) Non-AKI 
(40,905) 
Difference 
Laboratory Values (Means, Standard deviations) 
AST 29.99 
±18.12 
26.41 
± 15.25 
3.58  31.27 
± 17.85 
29.05 
± 17.79 
2.22 
Blood Bilirubin 0.6 
± 0.37 
0.57 
± 0.34 
0.03  0.6 
± 0.37 
0.58 
± 0.36 
0.02 
BP Diastolic 68.65 ± 
10.5 
70.25 
± 9.64 
-1.6 65.64 
± 8.38 
68.68 
± 8.31 
-3.04 
BP Systolic 131.22 
±19.76 
133.89 ± 
18.43 
-2.67 125.91 
± 15.79 
130.48 ± 
15.81 
-4.57 
BUN 20.55 ± 
9.67 
18.58 
± 7.66 
1.97 21.64 
± 9.5 
17.86 
± 7.73 
3.78 
Heart Rate 82.31 
±14.61 
79.8 
± 14.39 
2.51 81.65 
± 12.79 
77.79 
± 12.17 
3.86 
Platelet Count 220.52 
±87.79 
219.87 ± 
79.09 
0.65 217.41 
± 88.04 
212.36 ± 
80.65 
5.05 
Temperature 98.16 ± 
0.8 
98.14 
± 0.64 
0.02 98.22 
± 0.62 
98.13 
± 0.48 
0.09 
Troponin 0.33 
± 0.72 
0.29 
± 0.65 
0.04 0.38 
± 0.82 
0.38 
± 0.8 
0 
Comorbidities (Percentages) 
Coronary Artery Disease 0 0 0  0 0 0 
Diabetes 5.21 4.36 0.85  6.96 5 1.96 
Disorders of Lipoid 
Metabolism 1 1.68 -0.68 
 
1.94 2.26 -0.32 
Heart Failure 12.72 5.36 7.36  18.07 6.98 11.09 
Hypercalcemia 0.36 0.19 0.17 0.67 0.26 0.41 
Hyperlipidemia 2.27 3.6 -1.33 2.76 4.09 -1.33 
Hypertension 26.73 30.4 -3.67 40.33 37.79 2.54 
Pancreatitis 0.97 1.22 -0.25 1.27 1.35 -0.08 
Respiratory Failure 1.94 1.05 0.89 3.39 1.35 2.04 
Rhabdomyolysis 0.42 0.34 0.08 0.45 0.38 0.07 
Sepsis 5.33 3.69 1.64 7.36 4.31 3.05 
Thrombocytopenia 1.88 1.14 0.74 3.48 1.84 1.64 
Medications (Percentages) 
ACE Inhibitors 17.62 16.06 1.56  26.1 19.05 7.05 
ACE Inhibitors or NSAIDS or 
Diuretics 46.26 38.59 7.67 71.84 47.51 24.33 
ACE Inhibitors 
or ARB or NSAIDS or 
Diuretics 49.35 43.38 5.97 74.72 51.88 22.84 
Acylovir 1.18 0.79 0.39 2.36 1.11 1.25 
Aminoglycosides 0.27 0.08 0.19 0.54 0.16 0.38 
ARB 8.39 8.88 -0.49 12.44 9.96 2.48 
Cisplatin 0.33 0.02 0.31 0.7 0.07 0.63 
Diuretics 35.15 21.41 13.74 59.88 29.76 30.12 
K Sparing 5.24 2.37 2.87 8.08 3.28 4.8 
Lipid Lowering Drugs 37.63 39.03 -1.4 50.89 47.34 3.55 
NSAIDS 5.24 9.14 -3.9 10.81 11.92 -1.11 
Radiocontrast Dyes 16.65 18.15 -1.5 27.52 22.57 4.95 
 
2.4. Continual Prediction Model for AKI 
We first define three terms event, event-time and feature-snapshot that will be useful in describing our 
new continual prediction model. We call event as any change in the value of any of the features during a 
hospital stay. For example, an event occurs any time a new medication is prescribed, or a new 
comorbidity is recorded, or a new laboratory test result becomes available. If multiple of these changes 
occur at the same time (to be more precise, if multiple of these get recorded in the EHR with the same 
timestamp) then all are considered as one event. Admission and discharge are also regarded as events. We 
call event-time as the timestamp of an event as recorded in the EHR. Finally, we call the latest values of 
all the features at an event-time as its feature-snapshot. Figure 3 (a) shows a hypothetical illustrative 
timeline of a hospital stay with some events and their corresponding event-times and feature-snapshots. In 
our data, there were on average 21.5 (standard deviation=12.6) events per day per hospital stay. 
 
2.4.1. Applying the Model 
Once trained (we later describe how it is trained), our continual prediction model is applied to predict 
AKI at every event-time of a hospital stay starting from the admission time. There is no need to apply the 
model between two consecutive events because by definition no feature changes between two consecutive 
events therefore the model’s prediction will not change. To apply the model at an event-time, the values 
of the features are taken from that event-time’s feature-snapshot.  
 
Many machine learning methods give probability of their prediction, for example, in our task it is the 
probability that AKI will develop. Thus the continual prediction model’s predicted probability that AKI 
will develop dynamically changes during the course of a hospital stay as the feature values change. Figure 
3 (b) illustrates this for the example hospital stay shown above it. To contrast this, Figure 3 (c) shows the 
static nature of the one-time-at-24-hour prediction model’s prediction. Unlike one-time prediction 
models, the continual prediction model is able to take into account the latest medical status of the patient 
as it changes dynamically over the hospital stay. This helps the model in predicting AKI incidences more 
accurately that develop later in the hospital stay. Additionally, given that the continual prediction model is 
applied starting from the admission time, it cannot miss early AKI incidents the way a one-time 
prediction model misses those because the model is applied too late. Thus the continual prediction model 
circumvents the two problems of one-time prediction models pointed out earlier of either being applied 
too early to accurately predict AKI or being applied too late to prevent AKI. 
 
Although the continual prediction model gives probability of AKI at every event-time, it will be highly 
impractical to alert healthcare providers about the probability of AKI every time a feature changes. Hence 
an important question is – when is it appropriate to trigger an alarm for AKI as predicted by the model? In 
our method, we use a threshold (a parameter) and whenever the AKI prediction probability exceeds this 
threshold it is deemed that the model has predicted AKI which should be alerted to the providers. Figure 3 
(b) shows an example of AKI being predicted by the continual prediction model using a particular 
threshold value of 0.8 (this threshold value was arbitrarily chosen for illustration; for evaluation, threshold 
values between 0 and 1 in step-size of 0.01 were used to obtain different points on the ROC curve). The 
first event-time at which this happens is recorded as the time the model predicted AKI for that hospital 
stay. If the probability never exceeds the threshold over a hospital stay then it is deemed that the model 
did not predict AKI for that hospital stay.  
 
 Figure 3. An illustrative timeline of a hospital stay along with the AKI prediction probabilities of the 
continual and the one-time-at-24-hour prediction models. The continual prediction model predicts AKI 
once aminoglycoside is prescribed sometime after 24 hours from admission but the one-time-at-24-hour 
prediction model fails to predict AKI at 24 hours from admission. AKI is determined sometime after 36 
hours by the AKIN criteria. This is a hypothetical example for illustration purpose. 
 
In the hypothetical illustrative example shown in Figure 3, AKI develops after aminoglycoside is 
prescribed sometime after 24 hours from admission. The continual prediction model is able to predict 
AKI when aminoglycoside is prescribed (the AKI probability increases and exceeds the threshold). On 
the other hand, the one-time-at-24-hour prediction model fails to predict AKI because aminoglycoside 
was prescribed after 24 hours from admission. 
 
2.4.2. Evaluation 
For a hospital stay during which AKI developed, the continual prediction model must predict AKI (based 
on the threshold) by the time of AKI incidence otherwise it will be considered that the model missed it 
(predicting it later will be too late). In other words, to correctly predict AKI for a hospital stay, the 
continual prediction model’s prediction probability for AKI must be above the chosen threshold at least at 
one event-time before the time of AKI incidence. On the other hand, for a hospital stay during which AKI 
did not develop, the continual prediction model must not predict AKI at any event-time. In other words, to 
correctly predict non-AKI for a hospital stay, the continual prediction model’s prediction probability for 
AKI should not be above the chosen threshold at any event-time over the entire hospital stay. Please note 
that this is a very strict criterion for correct non-AKI prediction and given that the number of non-AKI 
hospital stays are more than 10 times the number of AKI hospital stays in our data this makes the task for 
the continual prediction model especially difficult. The threshold offers a trade-off between sensitivity 
and specificity. A higher threshold will increase the model’s specificity but decrease its sensitivity and 
vice-versa. The rest of the evaluation proceeds in the same way as for the one-time prediction models as 
described earlier. 
 
2.4.3. Training the Model 
For training the one-time-at-24-hour prediction model, it is clear that the feature values for positive (AKI) 
and negative (non-AKI) training examples must be collected at 24 hours from admission. However, for 
the continual prediction model, which has no specific time of prediction, an important question arises – 
what should be the time for collecting the feature values for positive and negative training examples? 
Ideally, for each hospital stay in the training data during which AKI developed, feature-snapshot of its 
each event-time before AKI should be used to create a positive example because when the model is 
applied it is expected to predict AKI during those events (sooner the better). Similarly, for each hospital 
stay in the training data during which AKI did not develop, feature-snapshot of its each event-time till the 
end of hospital stay should be used to create a negative example. However, this will result in an explosion 
of the number of training examples (0.48 million positive and 3.2 million negative examples in our data) 
which would require unreasonable amounts of computational time and memory for training machine 
learning methods. Also, any two consecutive feature-snapshots will minimally differ from each other 
hence most of the examples thus created will be largely repetitious.  
 
In this work, we decided to take feature-snapshot at the time AKI was determined (i.e. when the SCr 
measurement satisfied the AKIN criteria) for creating positive training examples, and at the time last SCr 
measurement was taken for creating negative training examples. This way we create only one training 
example per hospital stay thus keeping under control the computational time and memory requirement for 
training machine learning methods. We decided to use the time of AKI for creating positive training 
examples because it best represents the status of patients who have acquired AKI. We decided to use the 
time of last SCr for creating negative training examples because it shows that the patient was still 
considered prone to AKI. This way the model will learn to better distinguish between AKI and non-AKI 
cases. If we had used, for example, feature-snapshot of the discharge time for creating negative examples 
then the model may simply learn to predict whether the patient is about to get discharged or not. We also 
tried random event-times to create negative examples but that did not lead to any noticeable difference in 
the results. We want to point out that training a prediction model with the examples as described above is 
similar to the “AKI detection” model we had built in our past work [14]. However, that model was not 
applied continually and its purpose was to determine if AKI had already developed in order to prevent it 
from going undiagnosed.    
 
In our previous work [14] we had compared several machine learning methods for building AKI 
prediction models and had found logistic regression [38] to work best. Given that the goal of the current 
study was to compare the proposed continual prediction model with the traditional one-time prediction 
models, we used only logistic regression to build both types of models. Comparing different machine 
learning methods was not a goal of this study which we had done in our previous work. We used the 
Weka machine learning software [39] to build logistic regression models. Missing feature values were 
handled by Weka’s default mechanism for logistic regression in which missing values are replaced by the 
modes for nominal features and by the means for numeric features as computed from the training data. 
Given the unbalanced nature of our data with more than 10 times non-AKI examples than AKI examples, 
we used Weka’s cost-sensitive classifier whose weight for the minority class was decided out of 1, 2, 4, 6, 
…, 18, 20 through internal cross-validation within the training data.  
 
 
 3. Results and Discussion 
 
3.1. Continual vs. One-time Prediction Models 
Table 3 shows comparison between AUC obtained by the continual prediction model and by the one-
time-at-24-hour prediction model through 10-fold cross-validation using exactly the same folds. The first 
row shows results in which we exclude hospital stays in which AKI developed within 24 hours from 
admission (483 such hospital stays) because it is beyond the capacity of the one-time-at-24-hour 
prediction model to predict these AKI incidences. Continual prediction model obtained statistically 
significantly better AUC than the one-time prediction model (0.724 vs. 0.653; p < 0.05; two-tailed paired 
t-test).  
 
In the second row we show results for all hospital stays. In this comparison, all the 483 hospital stays in 
which AKI developed within 24 hours will be missed by the one-time-at-24-hour prediction model. As a 
result, its AUC dropped to 0.57 while the AUC of the continual prediction model was 0.709. Figure 4 
shows the corresponding ROC curves. Overall, this is a more realistic comparison because it does not 
artificially exclude the cases which are beyond the capacity of the one-time prediction model. However, 
in past the results for one-time prediction models were always reported after excluding these cases, hence 
those results looked better than how they were in reality. It should be noted that the ROC curve for the 
one-time-at-24-hour prediction model in Figure 4 does not end at the top right corner. The reason for this 
is that even with zero threshold value for confidence, which usually yields maximum sensitivity of 1, the 
one-time-at-24-hour model simply cannot predict those 483 AKI hospital stays because the prediction 
time of 24 hours is already too late for them. 
 
Table 3. Comparison of continual prediction model and one-time-at-24-hour predcition model for AKI. An 
AUC number in bold was found to be statistically significant compared to the AUC number in the same 
row (p < 0.05; two-tailed paired t-test).  
 AKI 
Hospital 
Stays 
Non-AKI 
Hospital 
Stays 
Continual Prediction 
Model AUC  
(95% CI) 
One-time-at-24-hour 
Prediction Model  AUC 
(95% CI) 
Excluding hospital 
stays in which AKI 
developed within 24 
hours from admission 
3303 40905 0.724 
(0.705, 741) 
0.653 
(0.641, 665) 
All hospital stays 3786 40905 0.709 
(0.690, 0.728) 
0.57 
(0.555, 0.584) 
 
In order to show that the continual prediction model is also better than other one-time prediction models 
besides the one-time-at-24-hour prediction model, we generated results for different one-time prediction 
models that predict from 0 hours (i.e. at the time of admission) to 120 hours from admission. Each of 
these models requires separate training and testing for its time of prediction. The second column of Table 
4 shows the results for all hospital stays. The next column shows results of evaluation after excluding 
hospital stays in which AKI developed before the time of prediction as well as after excluding hospital 
stays which were shorter than the time of prediction. Finally, for a direct comparison of all the models on 
the same set of hospital stays on which none of them was applied too late, results are also shown in the 
last column after excluding hospital stays in which AKI developed within 120 hours as well as after 
excluding hospital stays which were shorter than 120 hours. For comparison, the last row shows the 
corresponding results of the continual prediction model. 
 
  
Figure 4. ROC curves of the continual prediction model and the one-time-at-24-hour prediction model 
when evaluated on all hospital stays. 
 
It can be seen from Table 4 that none of the one-time prediction models does better than the continual 
prediction model. As we had pointed out earlier, if the one-time prediction is made too late then it would 
miss AKI cases that developed earlier. The drop in AUC in the second column clearly shows this. It is 
interesting to note that the last column of Table 3 changes very little over different times of one-time 
prediction models indicating that a later one-time prediction model is not necessarily better at predicting 
AKI incidences that develop later. This may seem counter-intuitive, but it has an explanation. Using 
information gain statistic [40] we show in the Appendix that the pre-admission features are the most 
important features for one-time prediction models. This is because these models are supposed to predict 
far ahead in time and hence the other features that later change over hospital stays are not helpful in 
making such early predictions. Hence all the one-time prediction models predominantly use pre-
admission features to make predictions. And given that the pre-admission features do not change over 
hospital stays, a later one-time prediction model is not necessarily better at predicting AKI that develop 
later. We also show in the Appendix that, in contrast, for the continual prediction model the features that 
change over hospital stays are the most important features.  
Table 4. Comparison of one-time prediction models with different times of predictions. All evaluation 
numbers are AUC. 
One-time prediction 
at X hours 
 
 
 
X = 
All hospital stays 
(AKI developed 
within X hours will 
be considered 
missed) 
(AKI: 3786; Non-
AKI: 40905) 
Excluding  hospital 
stays which were 
shorter than X 
hours or in which 
AKI developed 
within X  hours  
Excluding  hospital 
stays which were 
shorter than 120 
hours or in which 
AKI developed 
within 120  hours 
(AKI: 1493; Non-
AKI: 12274) 
0 0.653 0.653 0.597 
12 0.637 0.655 0.594 
24 0.570 0.653 0.592 
36 0.560 0.650 0.593 
48 0.525 0.641 0.595 
60 0.543 0.629 0.595 
72 0.535 0.634 0.607 
84 0.559 0.628 0.607 
96 0.553 0.624 0.609 
108 0.566 0.611 0.607 
120 0.560 0.607 0.607 
 
Continual  0.709 - 0.651 
 
3.2. Advance Prediction  
One can also evaluate retrospectively how far early could a model predict AKI before it developed. This 
may be desirable to know in order to have sufficient time to respond to prevent AKI. In Figure 5, we 
show how AUC varied with the number of hours in advance a model must predict AKI before it 
developed, i.e. it may predict earlier but if it predicted any later then it will be considered too late and the 
prediction will not count as correct. For example, if the model must predict AKI at least 12 hours in 
advance then its time of prediction must be 12 hours before AKI developed. For the one-time-at-24-hour 
prediction model the time of prediction is fixed at 24 hours, but for the continual prediction model the 
time of prediction is the first event-time when the AKI probability exceeds the threshold (see Figure 1 
illustration). For this plot, we only considered AKI incidences that developed at least 24 hours after 
admission for a fair comparison across all time lengths from 0 to 24 hours (for example, if AKI developed 
in less than 24 hours then one could not have possibly predicted it 24 hours in advance). We plotted the 
curves with 2 hour granularity which was sufficient to obtain smooth curves, they can be otherwise 
plotted at any granularity level. Please note that the continual prediction model still makes predictions 
continually, here we are only evaluating in 2 hour intervals how far in advance it could predict AKI  (i.e. 
AUC for prediction by 6 hours in advance, AUC for prediction by 8 hours in advance etc.). As one would 
expect, the figure shows that for both types of models it is harder to predict AKI more time in advance. 
The AUC seems to slowly drop almost linearly with the number of hours in advance by when the 
prediction is required. However, it can be seen that the performance of the one-time-at-24-hour model 
drops more precipitously than the continual prediction model.  
 
It can be seen from Figure 5 that the AUC of the one-time-at-24-hour prediction model for making 
prediction by 24 hours in advance is nearly 0.5. A random prediction model also gives AUC of 0.5 with a 
diagonal ROC curve. However, we want to point out that there is a different reason why the one-time-at-
24-hour prediction model obtains such low AUC for advance prediction. When the one-time-at-24-hour 
prediction model needs to predict AKI by 24 hours in advance, it simply cannot predict AKI incidences 
that occur between 24 hours and 48 hours of admission. Hence those incidences become out of reach for 
the model to predict and that lowers the maximum sensitivity it can obtain. Consequently, its ROC curve 
does not reach the top right corner. A similar situation was shown in Figure 4 for a curve that had AUC of 
0.57. It should be noted that in this situation a random prediction model applied to predict at 24 hours will 
obtain AUC lower than 0.5 (its ROC curve will not reach the top right corner either), hence the one-time-
at-24-hour learned prediction model is still doing better than a random prediction model. Of note, because 
continual prediction model has no fixed time of prediction, there are no AKI incidences which are beyond 
its reach to predict in advance. For instance, when the continual prediction model needs to predict AKI by 
24 hours in advance, it is possible for it to predict AKI incidences that occur between 24 hours and 48 
hours of admission by making those predictions any time between 0 and 24 hours of admission. 
 
We want to contrast our evaluation with a recent study [21] in which in order to evaluate the performance 
of an AKI prediction model to make predictions, say 24 hours in advance, the model was actually applied 
24 hours before each AKI incidence. As was pointed out in the Introduction, their framework of advance 
prediction is not possible to deploy in practice because one cannot know in advance the time of an AKI 
incidence in order to determine when the model should be applied (in fact, that defeats the very purpose 
behind the prediction model). In contrast, in our evaluation, a model makes prediction when it makes 
prediction (as depicted in the illustrative example in Figure 1) and it is then evaluated whether that 
prediction was made, say, by 24 hours in advance of the AKI incidence. Hence our evaluation does not 
require knowing the time of an AKI incidence beforehand in order to determine when to predict it. Our 
framework is thus deployable in practice for advance prediction and our evaluation also realistically 
measures the advance prediction performance.      
 
 
Figure 5. A graph showing how the prediction performance changed with the number of hours in advance 
by when a model must predict AKI. 
3.3. Dynamic Predictive Features 
Another advantage of our continual prediction framework is that we can directly observe how the model’s 
prediction dynamically changes as the values of the features change over the course of hospital stays. The 
third column of Table 5 shows the percentage of hospital stays over which a particular medication was 
prescribed or a particular comorbidity was diagnosed. The fourth (last) column shows how often the 
model’s prediction changed from non-AKI to AKI whenever the medication was prescribed or the 
comorbidity was diagnosed over the hospital stay (it is possible that other features could have also 
changed at the same time). One can compute these numbers for every confidence threshold but we are 
showing the combined results for all confidence thresholds instead of picking any particular threshold. 
The table shows only the top ten such features. Laboratory values are numeric features that can change 
multiple times during a hospital stay in different magnitudes hence they could not be included in this 
analysis. It can be seen from the table that prescription of medications cisplatin and aminoglycosides were 
most prominently associated with change in prediction from non-AKI to AKI. The third column shows 
that these were not prescribed frequently though. The next two medications to follow were diuretics and 
acyclovir. All these medications are, in fact, known for their nephrotoxicity. Hypercalcemia and 
respiratory failure were found to be the most prominent among comorbidities which when diagnosed 
during hospital stay were most often associated with change in prediction from non-AKI to AKI. Such 
dynamic information was never reported in the past work and could not have been obtained without a 
continual prediction model. 
 
Table 5. Top ten medications and comorbidity features whose prescription or diagnosis during hospital 
stay were associated with change in the model’s prediction from non-AKI to AKI. The numbers in the last 
column are average values obtained over all confidence thresholds.   
Rank Medication or Comorbidity 
Feature 
Percentage of hospital stays 
over which the feature 
changed (%) 
How often change in feature over 
hospital stay changed prediction 
from non-AKI to AKI (%) 
1 Cisplatin 0.123 25.6 
2 Aminoglycosides 0.186 15.4 
3 Hypercalcemia 0.311 5.81 
4 Diuretics 36.4 3.84 
5 Acyclovir 1.27  3.6 
6 ACE inhibitors or NSAIDS or 
Diuretics 
56.4 2.53 
7 ARB or ACE inhibitors or 
NSAIDS or Diuretics 
61.5 2.29 
8 Respiratory failure 1.59 2.17 
9 Rhabdomyolysis 0.403 2 
10 K sparing 4.19 1.86 
 
3.4. Limitations and Future Work 
Our data was limited to one system of hospitals which limits generalization. The data was obtained only 
from the structured part of EHR. In future, natural language processing techniques [41] could be used to 
extract AKI-relevant features and their values from the text part of EHR.  Our continual prediction model 
always used the latest values of all the features; in future, it could be improved by also taking into account 
the past values of the features and how they vary over time. Our study was retrospective and it remains to 
be seen how such a framework will perform when deployed. However, we point out that it should not be 
difficult to integrate our continual prediction framework in an EHR system because the trained logistic 
regression model is only a mathematical equation (this is also true for many other machine learning 
methods) which in order to make predictions only requires the latest values of patient variables and these 
values are already present in the EHR. The system can then be made to trigger an alarm whenever the 
AKI prediction probability exceeds the threshold set corresponding to the desired level of sensitivity and 
specificity.     
 
4. Conclusions 
We introduced a new framework of continual prediction from EHR data and applied it for predicting 
AKI. Instead of applying the trained model at a particular time as was done in the past, the continual 
prediction model was applied continually over entire hospital stay whenever any patient variable changed. 
Our experiments on a large dataset showed that the model out-performed one-time prediction models. 
Unlike one-time prediction models, the continual prediction model can take into account latest values of 
variables as they dynamically change over hospital stay. The continual prediction model also circumvents 
the shortcomings faced by one-time prediction models of either being applied too early to accurately 
predict AKI or being applied too late to prevent AKI.  
 
Conflict of Interest 
None. 
 
References 
 
1. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length 
of stay, and costs in hospitalized patients. Journal of the American Society of Nephrology. 
2005;16(11):3365-70. 
 
2. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a 
prospective study. The American journal of medicine. 1983;74(2):243-8. 
 
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. American Journal of Kidney 
Diseases. 2002;39(5):930-6. 
 
4. Thakar CV, Christianson A, Freyberg R, Almenoff P, Render ML. Incidence and outcomes of acute 
kidney injury in intensive care units: a Veterans Administration study. Critical Care Medicine. 
2009;37(9):2552-8. 
 
5. Kes P, Jukić NB. Acute kidney injury in the intensive care unit. Bosnian journal of basic medical 
sciences. 2010;10(Suppl 1):S8. 
 
6. Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Critical 
care medicine. 2007;35(8):1837-43. 
 
7. Sileanu FE, Murugan R, Lucko N, Clermont G, Kane-Gill SL, Handler SM, Kellum JA. AKI in low-
risk versus high-risk patients in intensive care. Clinical Journal of the American Society of Nephrology. 
2014:CJN-03200314. 
 
8. Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall 
CD, Govil D, Honoré PM. Epidemiology of acute kidney injury in critically ill patients: the multinational 
AKI-EPI study. Intensive care medicine. 2015;41(8):1411-23. 
 
9. Coca SG. Acute kidney injury in elderly persons. American Journal of Kidney Diseases. 
2010;56(1):122-31. 
10. Anderson S, Eldadah B, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kimmel PL, Molitoris 
BA, Murthy M, O'Hare AM, Schmader KE. Acute kidney injury in older adults. Journal of the American 
Society of Nephrology. 2011;22(1):28-38. 
 
11. Yamout H, Levin ML, Rosa RM, Myrie K, Westergaard S. Physician prevention of acute kidney 
injury. The American Journal of Medicine. 2015;128(9):1001-6. 
 
12. Sutherland SM, Chawla LS, Kane-Gill SL, Hsu RK, Kramer AA, Goldstein SL, Kellum JA, Ronco C, 
Bagshaw SM. Utilizing electronic health records to predict acute kidney injury risk and outcomes: 
                                                                                                                                                                           
workgroup statements from the 15 th ADQI Consensus Conference. Canadian Journal of Kidney Health 
and Disease. 2016;3(1):11. 
 
13. Hodgson LE, Sarnowski A, Roderick PJ, Dimitrov BD, Venn RM, Forni LG. Systematic review of 
prognostic prediction models for acute kidney injury (AKI) in general hospital populations. BMJ open. 
2017;7(9):e016591. 
 
14. Kate RJ, Perez RM, Mazumdar D, Pasupathy KS, Nilakantan V. Prediction and detection models for 
acute kidney injury in hospitalized older adults. BMC Medical Informatics and Decision Making. 
2016;16(1):39. 
 
15. Bedford M, Stevens P, Coulton S, Billings J, Farr M, Wheeler T, Kalli M, Mottishaw T, Farmer C. 
Development of risk models for the prediction of new or worsening acute kidney injury on or during 
hospital admission: a cohort and nested study. Health Service Delivery Research. 2016;4(6). 
 
16. Cronin RM, VanHouten JP, Siew ED, Eden SK, Fihn SD, Nielson CD, Peterson JF, Baker CR, Ikizler 
TA, Speroff T, Matheny ME. National Veterans Health Administration inpatient risk stratification models 
for hospital-acquired acute kidney injury. Journal of the American Medical Informatics Association. 
2015;22(5):1054-71. 
 
17. Schneider DF, Dobrowolsky A, Shakir IA, Sinacore JM, Mosier MJ, Gamelli RL. Predicting acute 
kidney injury among burn patients in the 21st century: a CART analysis. Journal of Burn Care & 
Research: Official Publication of the American Burn Association. 2012;33(2):242. 
 
18. Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, 
Weintraub WS, Curtis JP, Messenger JC. Validated contemporary risk model of acute kidney injury in 
patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data 
Registry Cath‐PCI Registry. Journal of the American Heart Association. 2014;3(6):e001380. 
 
19. Slankamenac K, Beck-Schimmer B, Breitenstein S, Puhan MA, Clavien PA. Novel prediction score 
including pre-and intraoperative parameters best predicts acute kidney injury after liver surgery. World 
Journal of Surgery. 2013;37(11):2618-28. 
 
20. Demirjian S, Schold JD, Navia J, Mastracci TM, Paganini EP, Yared JP, Bashour CA. Predictive 
models for acute kidney injury following cardiac surgery. American Journal of Kidney Diseases. 
2012;59(3):382-9. 
 
21. Cheng P, Waitman LR, Hu Y, Liu M. Predicting Inpatient Acute Kidney Injury over Different Time 
Horizons: How Early and Accurate? In Proceedings of the American Medical Informatics Association 
(AMIA) Annual Symposium, pp. 565-574, Washington, DC, November 2017. 
  
22. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 
1986:121-30. 
 
23. Miller Jr RG. Survival Analysis. 2nd ed. John Wiley & Sons; 1998. 
 
24. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. 
Oxford: University Press; 2003. 
 
                                                                                                                                                                           
25. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS. A 
predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553-
9. 
 
26. Zhou J, Liu J, Narayan VA, Ye J. Modeling disease progression via multi-task learning. NeuroImage. 
2013;78:233-48. 
 
27. Liu YY, Ishikawa H, Chen M, Wollstein G, Schuman JS, Rehg JM. Longitudinal modeling of 
glaucoma progression using 2-dimensional continuous-time hidden markov model. In International 
Conference on Medical Image Computing and Computer-Assisted Intervention 2013:444-451. 
 
28. Sukkar R, Katz E, Zhang Y, Raunig D, Wyman BT. Disease progression modeling using hidden 
Markov models. In Engineering in Medicine and Biology Society (EMBC), 2012 Annual International 
Conference of the IEEE 2012 (pp. 2845-2848). IEEE. 
 
29. Moskovitch R, Shahar Y. Classification-driven temporal discretization of multivariate time series. 
Data Mining and Knowledge Discovery. 2015;29(4):871-91. 
 
30. Arandjelović O. Discovering hospital admission patterns using models learnt from electronic hospital 
records. Bioinformatics. 2015;31(24):3970-6. 
31. Vasiljeva I, Arandjelović O. Diagnosis Prediction from Electronic Health Records Using the Binary 
Diagnosis History Vector Representation. Journal of Computational Biology. 2017;24(8):767-86. 
32. Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV, Tolwani AJ, Waikar SS, 
Weisbord SD. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney 
injury. American Journal of Kidney Diseases. 2013;61(5):649-72. 
 
33. Drawz PE, Miller RT, Sehgal AR. Predicting hospital-acquired acute kidney injury—a case-controlled 
study. Renal Failure. 2008;30(9):848-55. 
 
34. Matheny ME, Miller RA, Ikizler TA, Waitman LR, Denny JC, Schildcrout JS, Dittus RS, Peterson JF. 
Development of inpatient risk stratification models of acute kidney injury for use in electronic health 
records. Medical Decision Making. 2010;30(6):639-50. 
 
35. Kane-Gill SL, Sileanu FE, Murugan R, Trietley GS, Handler SM, Kellum JA. Risk factors for acute 
kidney injury in older adults with critical illness: a retrospective cohort study. American Journal of 
Kidney Diseases. 2015;65(6):860-9. 
 
36. Campbell I. Chi‐squared and Fisher–Irwin tests of two‐by‐two tables with small sample 
recommendations. Statistics in medicine. 2007;26(19):3661-75. 
 
37. Japkowicz N, Shah M. Evaluating Learning Algorithms: A Classification Perspective. Cambridge: 
University Press; 2011. 
 
38. Hosmer Jr DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression. 3rd ed. Hoboken, NJ: John 
Wiley & Sons; 2013. 
 
39. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH. The WEKA data mining 
software: an update. ACM SIGKDD Explorations Newsletter. 2009;11(1):10-8. 
                                                                                                                                                                           
 
40. Kent JT. Information gain and a general measure of correlation. Biometrika 1983;70(1):163-173. 
 
41. Demner-Fushman D, Chapman WW, McDonald CJ. What can natural language processing do for 
clinical decision support? Journal of Biomedical Informatics. 2009;42(5):760-72. 
 
 
 
Appendix 
 
 
To see the difference between continual and one-time prediction frameworks, we have shown below the 
information gain statistic for all the features. First it is shown for the data that is used to train the one-
time-at-24-hour prediction model and next for the data that is used to train the continual prediction model 
(information gain is a property of the data and is independent of any model). The Weka machine learning 
software was used to obtain these. A higher value of the information gain statistic for a feature means that 
the feature is more helpful in distinguishing between AKI and non-AKI examples. The features are shown 
sorted in the decreasing order of information gain. It can be observed that for the one-time prediction, the 
most important features are pre-admission comorbidities and pre-admission medications. The features that 
change over hospital stays are not important for a one-time prediction because such a model is supposed 
to make predictions far ahead in time (for example, AKI incidence may occur even after 120 hours from 
admission) and at 24 hours from admission these features are not helpful in distinguishing between AKI 
and non-AKI hospital stays (as indicated by their low information gain statistic). We obtained similar 
trend of information gain statistic for other one-time prediction models as well. This also shows why a 
later one-time prediction model is not necessarily better at predicting AKI that develop later (see paper’s 
Table 4 last column which changes very little). On the other hand, for continual prediction the features 
that change during hospital stays are the most important features because they are helpful in 
distinguishing between AKI and non-AKI hospital stays. 
 
1. Features given to the one-time prediction model that predicts at 24 hours from admission ranked by the 
information gain statistic. Preadmission features are the top features. 
 
Information 
Gain 
Feature 
0.006935 Preadmission Diuretics 
0.006867 Preadmission Heart Failure 
0.006867 Preadmission Congestive Heart Failure 
0.005041 Prior AKI 
0.004813 Preadmission Respiratory Failure 
0.003634 Preadmission K Sparing 
0.002644 Preadmission Radiocontrast Dyes 
0.002591 Preadmission Diabetes 
0.002451 Preadmission Sepsis 
0.002281 Preadmission ACE Inhibitors or NSAIDS or 
Diuretics 
0.002082 Preadmission ARB or ACE Inhibitors or NSAIDS 
or Diuretics 
                                                                                                                                                                           
0.001865 Preadmission ACE Inhibitors 
0.001715 Preadmission Coronary Artery Disease 
0.001107 Preadmission Lipid Lowering Drugs 
0.000888 BP Systolic 
0.000826 Preadmission Hypertension 
0.000821 Preadmission ARB 
0.000737 Race 
0.000735 Preadmission Thrombocytopenia 
0.000704 BP Diastolic 
0.00041 Alcohol 
0.000345 Tobacco 
0.000327 Gender 
0.000326 Heart Rate 
0.000313 BMI 
0.000281 Preadmission Aminoglycosides 
0.00025 BUN 
0.000223 Hypertension 
0.000153 Drug 
0.000147 Preadmission Hypercalcemia 
0.000123 Preadmission Acyclovir 
8.24E-05 Preadmission Cisplatin 
7.97E-05 Preadmission Disorders of Lipoid Metabolism 
5.26E-05 Heart Failure 
5.26E-05 Congestive Heart Failure 
4.46E-05 AST 
4.11E-05 Preadmission Rhabdomyolysis 
3.79E-05 NSAIDS 
3.41E-05 Diuretics 
2.63E-05 Respiratory Failure 
1.89E-05 Thrombocytopenia 
1.85E-05 Sepsis 
1.7E-05 Preadmission NSAIDS 
7.72E-06 Troponin 
7.6E-06 Pancreatitis 
6.18E-06 Disorders of Lipoid Metabolism 
5.07E-06 Hypercalcemia 
4.03E-06 Preadmission Hyperlipidemia 
2.53E-06 Rhabdomyolysis 
2.53E-06 ACE Inhibitors 
1.19E-06 Diabetes 
1.08E-06 ARB or ACE Inhibitors or NSAIDS  or Diuretics 
1.08E-06 ACE Inhibitors or NSAIDS or Diuretics 
                                                                                                                                                                           
9.58E-07 Radiocontrast Dyes 
2.63E-09 Hyperlipidemia 
0 Blood Bilirubin 
0 Acyclovir 
0 Platelets 
0 Preadmission Pancreatitis 
0 Coronary Artery Disease 
0 Temperature 
0 Cisplatin 
0 Aminoglycosides 
0 K Sparing 
0 Lipid Lowering Drugs 
0 ARB 
0 Age 
 
 
2. Features given to the continual prediction model ranked by the information gain statistic. Features that 
change during hospital stays are the top features. 
 
Information 
Gain 
Feature 
0.015545 Diuretics 
0.014529 BP Systolic 
0.012971 BP Diastolic 
0.008671 ACE Inhibitors or NSAIDS or Diuretics 
0.008189 Heart Rate 
0.00816 Preadmission Diuretics 
0.00748 ARB or ACE Inhibitors or NSAIDS or Diuretics 
0.007039 Preadmission Heart Failure 
0.007039 Preadmission Congestive Heart Failure 
0.006287 Congestive Heart Failure 
0.006287 Heart Failure 
0.00597 Temperature 
0.005515 Prior AKI 
0.004994 Preadmission Respiratory Failure 
0.004883 BUN 
0.003912 Preadmission K Sparing 
0.003288 Platelets 
0.00309 Preadmission Diabetes 
0.002884 Preadmission Radiocontrast Dyes 
0.002803 Preadmission ACE Inhibitors or NSAIDS or 
Diuretics 
0.002744 Preadmission Sepsis 
                                                                                                                                                                           
0.002601 Preadmission ARB or ACE Inhibitors or NSAIDS 
or Diuretics 
0.00222 Preadmission ACE Inhibitors 
0.00206 K Sparing 
0.001759 Preadmission Coronary Artery Disease 
0.001608 AST 
0.001371 Preadmission Lipid Lowering Drugs 
0.001154 Respiratory Failure 
0.001153 Preadmission Hypertension 
0.001094 BMI 
0.000995 Preadmission ARB 
0.000986 Sepsis 
0.000881 Preadmission Thrombocytopenia 
0.000803 Race 
0.000802 Cisplatin 
0.000802 ACE Inhibitors 
0.000416 Acyclovir 
0.000403 Alcohol 
0.000394 Thrombocytopenia 
0.000377 Tobacco 
0.000356 Hyperlipidemia 
0.000339 Radiocontrast Dyes 
0.000327 Diabetes 
0.000295 Blood Bilirubin 
0.000255 Gender 
0.000244 Preadmission Aminoglycosides 
0.000225 Aminoglycosides 
0.000188 Hypercalcemia 
0.000185 Drug 
0.000139 ARB 
0.000132 NSAIDS 
0.00013 Preadmission Acyclovir 
0.000128 Preadmission Hypercalcemia 
0.000116 Troponin 
7.82E-05 Preadmission Disorders of Lipoid Metabolism 
6.82E-05 Preadmission Rhabdomyolysis 
4.65E-05 Preadmission Cisplatin 
2.88E-05 Disorders of Lipoid Metabolism 
2.01E-05 Rhabdomyolysis 
1.25E-05 Hypertension 
7.27E-06 Lipid Lowering Drugs 
6.95E-06 Preadmission NSAIDS 
                                                                                                                                                                           
2.86E-06 Coronary Artery Disease 
1.86E-06 Preadmission Hyperlipidemia 
2.95E-07 Pancreatitis 
0 Preadmission Pancreatitis 
0 Age 
 
